|
May 2
|
NuGen Medical Devices Full Year 2023 Earnings: CA$0.056 loss per share (vs CA$0.062 loss in FY 2022)
|
|
Nov 2
|
MedTech Industry Leader Ian Heynen Commences CEO Role at NuGen
|
|
Aug 4
|
NuGen Provides Corporate Update
|
|
Apr 27
|
NuGen Medical Devices begins feasibility study in the Netherlands for InsuJet and Ozempic
|